We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Third Rock Ventures Launches Jounce Therapeutics

News   Feb 15, 2013

 
Third Rock Ventures Launches Jounce Therapeutics
 
 
 

RELATED ARTICLES

Dual Anthrax-Plague Vaccine Effective in Multiple Animal Models

News

A dual vaccine against the causative agents of anthrax and the plague is effective in three animal models.

READ MORE

Immune Culprits Linked to Inflammation and Bone Loss in Gum Disease

News

Microbes in the mouth trigger specialized immune cells that inflame and destroy tissues, leading to bone loss associated with severe gum disease.

READ MORE

150-Year-Old Drug Could Improve Cancer Radiation Therapy

News

A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE